Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Empowering Women in Biotech

The Empowering Women in Biotech event, hosted by Waters Corporation on Thursday 3rd April 2025, aims to bring together professionals from the biotech and life [...]

Go to Top